TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
121 hedge funds and large institutions have $222M invested in Tvardi Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
-6
Holders Change %
-4.72%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
30
Reduced
35
Closed
20
Calls
$3.9M
Puts
$7.22M
Net Calls
-$3.33M
Net Calls Change
-$1.44M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$7.96M |
| 2 |
NC
Nexthera Capital
New York
|
+$4.35M |
| 3 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$2.49M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.73M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.11M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.28M |
| 2 |
Morgan Stanley
New York
|
-$1.8M |
| 3 |
Millennium Management
New York
|
-$1.37M |
| 4 |
Squarepoint
New York
|
-$1.08M |
| 5 |
Goldman Sachs
New York
|
-$602K |
